Toku Eyes
About
Window to your future health
Toku Eyes has assembled a team of clinicians, technologists and business experts to develop proprietary algorithms that provide inexpensive, convenient AI-based health assessments through retinal imaging. Our initial focus is on addressing the significant challenges that prevent early screening and health-risk assessment for people living with diabetes and those at risk of Cardiovascular disease.
Our technology is non-invasive and designed to work anywhere, with immediate results for each patient, allowing early medical intervention. Our risk assessment models give life to the saying, "If you can see the future, you can change it".
- Location
- Auckland
- Website
- Visit website
- Founded
- 2018
- Employees
- 11-50
- Industry
- HealthTech
- Funding stage
- Seed
The Matchstiq Top 2025
Snapshot of Toku Eyes
Seeing More Than Meets the Eye
Toku Eyes is transforming eye exams into a window for early detection of chronic disease.
Using advanced AI, Toku's software analyses images of the retina to assess cardiovascular risk, detect early signs of type 2 diabetes, and provide a fuller picture of systemic health—all from a simple eye scan.
Founded by Associate Professor Ehsan Vaghefi and born out of research from the University of Auckland, Toku Eyes is on a mission to make preventive healthcare more accessible and affordable. The platform is designed to be integrated into optometry clinics, pharmacies, and primary care, enabling faster screening and diagnosis without waiting for specialist referrals.
Toku recently secured NZ$13 million in Series A funding led by US optical giant National Vision and Japan’s Topcon Healthcare, setting the stage for expansion into North America and beyond. With regulatory approvals already in place in the UK and Europe, Toku Eyes is scaling rapidly and reshaping the future of preventive care.
Why Toku Eyes Is a Great Place to Work
Science-Driven, Impact-Led Toku is applying world-class research to solve a massive global problem: how to detect chronic health issues earlier and more affordably. Your work will have real impact on lives worldwide.
Global Backing, Global Opportunity With backing from some of the biggest players in healthcare and optics, including National Vision and Topcon, Toku is well positioned to scale internationally, with the US market next in sight.
Fast-Moving and Mission-Focused The team combines academic rigour with startup agility. You’ll be joining a passionate, close-knit group committed to using AI for social good.
Homegrown Innovation Headquartered in Auckland and connected to top research institutions, Toku is proud to be a New Zealand company building breakthrough healthtech for the world.